GlassScriptPhysician profile
Petar Vukasin
NPI 1659385516
$33,690.02
in general payments reported to CMS, 2019-2025
7 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2021: $19K · 2022: $9,406 · 2023: $1,979 · 2024: $3,000 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $1,313 · Food and Beverage: $870 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $1,312.54 |
| Food and Beverage | $869.98 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $33,253.60 | 2019-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $159.43 | 2025 | Signia |
| Medtronic Vascular, INC. | $151.41 | 2019 | |
| Baxter Healthcare | $60.57 | 2025 | Tisseel |
| Myriad Genetic Laboratories, INC. | $30.93 | 2023 | Myrisk |
| Acell, INC. | $18.44 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.64 | 2023 | Rebyota |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petar Vukasin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.